Drug Discovery Articles
Computerized technologies to reach $6bn by 2008
8 July 2002
Pfizer expands ViroLogic agreement
24 June 2002
Charles River acquires Biological Labs Europe
17 June 2002
Celera restructuring
17 June 2002
Libraria appoints new CEO
10 June 2002
LION seeks drug discovery partner
10 June 2002
Pharma firms turning to bio-chip ventures
3 June 2002
Marc Vasseur steps up at Genset
27 May 2002
Improvements for GPC Biotech's 1st qtr
27 May 2002
Dutch Screentec BV changes name to Kiadis BV
13 May 2002
R&D boost for protein array sales: study
13 May 2002
Platform and SciTegic enter partnership
6 May 2002
Karo Bio drops stock option plan
29 April 2002
Celera to focus on genetic diagnosis and drug discovery
29 April 2002
ArQule's 1st-qtr revenues flat
29 April 2002
New drugs needed to reach $3,000bn market by 2020
29 April 2002
Callisto signs pact with Array BioPharma
29 April 2002
Conference
22 April 2002
Plexxikon raises $27 million
22 April 2002
MelTec/MyoContract partner on DMD
15 April 2002
Novartis researchers honored by AACR
15 April 2002
Hungary's Richter suing Japanese firms
15 April 2002
Ambit and AstraZeneca announce collaboration
8 April 2002
GPC biotech revenues leap, net loss narrows
1 April 2002
BioFocus posts 95% sales increase
1 April 2002
GPC biotech revenues leap, net loss narrows
1 April 2002
Compugen and Millennium sign protein pact
25 March 2002
ConjuChem signs deal with Suntory
25 March 2002
Extended collaboration for Aventis and Coley
25 March 2002
Daiichi signs up with Gene Logic
25 March 2002
LION Bioscience and GeneProt team up on proteomics
25 March 2002
Medicure starts trading on Toronto SE
25 March 2002
KaroBio wins drug discovery award
18 March 2002
Ionix and Xenome sign toxin deal
11 March 2002
Orchid allies with First Genetic
11 March 2002
Profits down at the UK's Genetix
11 March 2002
Strong growth in 2001 for Amersham
4 March 2002
Tokyo pharma stocks - week to February 25
4 March 2002
Autogen's genetic profiling plan in Tonga opposed
25 February 2002
Ricerca forges link with Indian biotech firm gvk
25 February 2002
LION continues streamlining for growth
25 February 2002
Strong sales rise at Karo Bio
18 February 2002
Chugai names vp, discovery biology
18 February 2002
Cyprotex sets out full prospectus for UK AIM admission
18 February 2002
LION sells stake in Tripos for $22.5 mill
18 February 2002
Corvas' matriptase inhibitor shows promise
18 February 2002
Evotec and Ionix to link up on analgesic R&D
11 February 2002
GSK not spinning off R&D centers - CEO
11 February 2002
GSK to sell off research units?
4 February 2002
Protein Design Labs selling small-molecule business
4 February 2002
Roche and deCODE move from target to drug discovery in alliance
4 February 2002
World bioinformatics market to reach $1.7 billion by 2006
28 January 2002
Eisai, Neurogenetics extend Alzheimer's disease agreement
28 January 2002
SignalGene selects lead anti-angiogenic drug
28 January 2002
Protedyne introduces system to accelerate drug discovery
28 January 2002
Astex unveils new facility in UK
28 January 2002
Hungarian firms making drug discovery progress.
21 January 2002
Array BioPharma and Pfizer forge collaboration.
21 January 2002
Cellzome publishes yeast proteome map.
21 January 2002
LION Bioscience acquires NetGenics of the USA to broaden its
21 January 2002
Shimadzu claims advance with mass spectrometer product.
21 January 2002
Amgen forms drug discovery link with Denmark's Acadia.
21 January 2002
Arrow acquires OGT array technology.
21 January 2002
IDEC and ExonHit sign target discovery agreement
14 January 2002
Structural GenomiX signs deal with Aventis
14 January 2002
Mitokor raises $25 million
7 January 2002
Astex raises further L5.7 million
7 January 2002
Archemix licenses aptamers to Noxxon
7 January 2002
Syrrx Closes $18.5 million financing
7 January 2002
Exelixis sets exchange ratio for Genomica acquisition
7 January 2002
Isis and Circadian form Antisense Therapeutics
7 January 2002
GeneFormatics/IBM sign discovery deal
7 January 2002
Boeh Ingelheim and Structural sign HIV deal
7 January 2002
BioFocus signs agreement with GSK
7 January 2002
B-MS predicts EPS decline in 2002
7 January 2002
Exelixis sets exchange ratio for Genomica acquisition
27 December 2001
Syrrx Closes $18.5 million financing
27 December 2001
Mitokor raises $25 million
21 December 2001
Isis and Circadian form Antisense Therapeutics
20 December 2001
GeneFormatics/IBM sign discovery deal
19 December 2001
Astex raises further L5.7 million
19 December 2001
Boeh Ingelheim and Structural sign HIV deal
18 December 2001
BioFocus signs agreement with GSK
17 December 2001
B-MS predicts EPS decline in 2002
17 December 2001
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
